Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Is PTSC(indirectly) on the hook for part of Brown's judgment
"3.5% of total MMP revenue coming into PDS". :::::::: at one point TPL was getting 15% off the top, were they not? Surely that was supposed to covered costs such as payments owed to Brown and others.... Also, how is the Brown judgement monetarily split pre- and post- the creation of PDS?
Share
New Message
Please login to post a reply